Report Number : 2721-001
Antisense Therapeutics: The Emerging World Market
Review of current research, including factors impacting advancement, such as drug delivery limitations
Countries Covered : World
Scope : 97pp Date : 2002 Price : $2,500

Report Number : 2721-001B
Glycomics: The Emerging World Pharma Market
World and US market sizes and shares in the glycomics field; examination of the leading companies and their pipeline products
Countries Covered : World
Scope : 200+pp Date : 2003 Price : $2,395

Report Number : 2721-001F
The Future of Diabetes Diagnostics: Monitoring & Management in 2010
Survey of the converging technological and market developments to extrapolate the shape and value of the market for new monitoring and treatment technologies
Countries Covered : World
Scope : 182pp Date : 2001 Price : $2,400

Report Number : 2721-001K
Vaccines 2003: World Markets and Developments
Review of trends in vaccine strategy; commercialisation of new therapeutic vaccines; technological advancements in vaccine research. Market forecasts through 2007. Includes pediatric vaccines, adult at-risk vaccines, therapeutic vaccines, overall world vaccine markets, major players in vaccine markets
Countries Covered : World
Scope : 200pp Date : 2003 Price : $2,995

Report Number : 2721-001N
Anemia Management: World Drug Markets
Clinical and market positioning data on anemia treatments and management, with special emphasis on anemia associated with chronic disease. Diseases associated with anemia that are discussed are: chronic kidney disease, cancer, HIV/AIDS, hepatitis, autoimmune diseases, cardiovascular disease
Countries Covered : World
Scope : 250+pp Date : 2003 Price : $2,195

Report Number : 2721-002
Market Dynamics 1999 Arthritis: Seven-Country Analysis & Perspective
Countries Covered : World
Date : 1999 Price : £ 2,995

Report Number : 2721-003
Market Dynamics 1999 Asthma: Seven-Country Analysis & Perspective
Countries Covered : World
Date : 1999 Price : £ 2,995

Report Number : 2721-004
Market Dynamics 1999 Diabetes: Seven-Country Analysis & Perspective
Countries Covered : World
Date : 1999 Price : £ 2,995

Report Number : 2721-005
Immune Disorders & Inflammation Drugs of Tomorrow
Quantitative pipeline analysis to 2005
Countries Covered : World
Date : 1999 Price : £ 2,995

Report Number : 2721-006
Market Dynamics Bacterial Infections: Seven-Country Analysis & Perspective
Countries Covered : World
Date : 1999 Price : £ 2,995

Report Number : 2721-007
Market Dynamics Fungal Infections: Seven-Country Analysis & Perspective
Countries Covered : World
Date : 1999 Price : £ 2,995

Report Number : 2721-008
Insulin Delivery System: The State-of-the-Science & Market Opportunities
Evaluates market trends and future potential for major insulin delivery mechanisms; identifies market drivers and restraints
Countries Covered : World
Scope : 40pp Date : 2003 Price : $500

Report Number : 2721-009
Lifestyle Drugs Outlook to 2005
Market analysis and forecasts to 2005: impotence, erectile dysfunction, obesity, alopecia, depression, oral viagra, contraception, skin aging
Countries Covered : World
Scope : 150pp Date : 1999 Price : £ 495

Report Number : 2721-010
Cardiovascular Drug News (CVDN)
General development news and international conference listings, including arrythmias/cardiac failure, antihypertensives/hypotension, circulatory disorders, anticoagulants/antithrombotics and fibrinolytics, hypolipidaemic agents, R&D highlights from international conferences
Countries Covered : World
Scope : 24-36pp Price : £ 475 Frequency : Monthly

Report Number : 2721-010D
Anti-Infective Drug News (AIDN)
Reports the latest commercial developments in the anti-infective drug market - including product news, antibacterials, antivirals, agreement news, antifungals, HIV/AIDS & related complications, R&D news, antimycobacterials and antiprotozoals/anthelmintics
Countries Covered : World
Scope : 28-42pp Price : £ 475 Frequency : Twice a Month

Report Number : 2721-011
Cancer Drugs of Tomorrow
A quantitative pipeline analysis to 2005
Countries Covered : World
Date : 1999 Price : £ 1,762

Report Number : 2721-012
Pharmacoeconomics in Cancer
Countries Covered : World
Date : 1999 Price : £ 1,762

Report Number : 2721-013
The Next Generation Antifungals: Triazoles vs. Peptides
Countries Covered : World
Date : 2002 Price : $495

Report Number : 2721-014
Cardiovascular Drugs of Tomorrow: A Quantitative Pipeline Analysis to 2005
Countries Covered : World
Date : 1999 Price : £ 1,762

Report Number : 2721-015
Pain Therapeutics: A Strategic Re-evaluation
Pain management; analgesic drugs; current pain relief; pain pharmacotherapy
Countries Covered : World
Scope : 198pp Date : 2000 Price : £ 745

Report Number : 2721-016
Antidepressants: World Prescription Drug Markets
Analysis of the US and key world markets for prescription antidepressants, including current and future trends in key disease and product areas, and a review of leading products, pipeline compounds and companies
Countries Covered : World
Scope : 150+pp Date : 2003 Price : $2,395

Report Number : 2721-016B
Anti-infectives I: World Market for Antivirals
Drugs used to treat: hepatitis B, hepatitis C, herpes, HIV, other viral infections (influenza, respiratory syncytial virus, rhinovirus)
Countries Covered : World
Scope : 250+pp Date : 2003 Price : $2,495

Report Number : 2721-016D
Anti-infectives II: World Market for Antibiotics
Conditions for treatment with antibiotics; the types of antibiotics available; how the various classes differ; new antibiotics currently in development; the current market for antibiotic drugs by class; the competitive positions of the major players in the antibiotic market; the key issues facing developers of antibiotic drugs
Countries Covered : World
Scope : 150+pp Date : 2004 Price : $2,495

Report Number : 2721-016F
Anti-infectives III: Antifungals and Other Therapies
Global market sizes, projections, and shares; competitive analysis of major players
Countries Covered : World
Date : 2004 Price : On Request

Report Number : 2721-016H
Cardiovascular Drugs: World Market Analysis
Current treatments and therapeutics in development; estimate of market sizes and projections based on drug class and geographic region. Major competitors examined and profiled
Countries Covered : World
Date : 2004 Price : On Request

Report Number : 2721-016J
Autoimmune Disease Therapeutics Worldwide: Markets & Developments
Rheumatoid arthritis, systemic lupus erythematosus, multiple sclerosis, thyroid disease, Sjogren's syndrome, myasthenia gravis. New treatments now available and being developed; current and projected market sizes and shares for the treatments of the disorders; companies developing new treatments; the impact of recent legislation and funding impacting R&D
Countries Covered : World
Scope : 450pp Date : 2002 Price : $2,500

Report Number : 2721-016L
Gastrointestinal Disorder Drugs: World Markets and Advances
Analyses of the total global market, as well as markets in the US, EUrope, and Japan, for pharmaceutical therapeutics to treat: gastroesophageal reflux disease, peptic ulcer disease, Crohn's disease, ulcerative colitis, and irritable bowel syndrome
Countries Covered : World
Scope : 455pp Date : 2002 Price : $1,995

Report Number : 2721-016N
Pulmonary/Lung Disease Therapeutics: Worldwide Markets and Developments
Analyses of the US and world markets for drug therapeutics to treat pulmonary/lung diseases and disorders. Covers COPD asthma, cystic fibrosis, pulmonary fibrosis, pulmonary hypertension, pulmonary embolism, pulmonary sarcoidosis, bronchopulmonary dysplasia, respiratory distress syndrome
Countries Covered : World
Scope : 364pp Date : 2002 Price : $1,995

Report Number : 2721-016P
The World Market for Dermatologic/Skin Therapeutics
Coverage of the worldwide dermatologic drug market, with emphasis on the US market. Market sizes and projections provided in US dollars at the manufacturer's level for the years 2001-2007. Covers psoriasis scleroderma; eczema/atopic dermatitis; acne; melanoma/skin cancer
Countries Covered : World
Scope : 364pp Date : 2003 Price : $2,395

Report Number : 2721-016R
Osteoporosis Drug Treatment
World market analysis and disease management considerations. Growth projections presented, included estimated growth by geographic region.Contains drug classes available to treat or prevent osteoporosis; current US and worldwide markets for osteoporosis; market predictions for 2002-2006; current and evolving market trends
Countries Covered : World
Scope : 170pp Date : 2003 Price : $1,995

Report Number : 2721-016T
Pain Management: World Prescription Drug Markets
Current and future sizes and growth rates prevailing in the global, US and major regional markets for pain management prescription products; pipeline compounds likely to drive future growth; leading competitors in this market, currently and in the future
Countries Covered : World
Scope : 276pp Date : 2003 Price : $2,395

Report Number : 2721-016V
Neurological Trauma Therapeutics: Markets and Developments
Projected pharma market sizes for pharmaceutical agents to treat specific neurological trauma disorders; major players and their most important products; the regulatory environment influencing diagnosis and treatment
Countries Covered : World
Scope : 264pp Date : 2002 Price : $2,295

Report Number : 2721-016X
Angiogenesis Inhibitors and Stimulators: The Emerging World Market
Types of therapies in the development pipeline (status of clinical trials, target launch dates and indications); technical challenges facing developers; profiles of the companies developing these products
Countries Covered : World
Scope : 156pp Date : 2002 Price : $1,995

Report Number : 2721-017
Immune Disorders and Inflammation Drugs of Tomorrow
Quantitative pipeline analysis to 2005
Countries Covered : World
Date : 1999 Price : £ 1,762

Report Number : 2721-020
Antiviral and Antifungal Drugs of Tomorrow
Countries Covered : World
Date : 1999 Price : £ 1,762

Report Number : 2721-031B
Allergic Rhinitis
Pharmaceuticals industry
Countries Covered : World
Date : 2001 Price : £ 1,399

Report Number : 2721-031D
Alzheimer's Disease
Pharmaceuticals industry
Countries Covered : World
Date : 1999 Price : £ 475

Report Number : 2721-031K
Analgesia
Pharmaceuticals industry - pain relief
Countries Covered : World
Date : 2000 Price : £ 495

Report Number : 2721-031M
Angiogenesis Players
Pharmaceuticals industry - angiogenesis research
Countries Covered : World
Date : 1999 Price : £ 375

Report Number : 2721-031P
Antibiotics
Pharmaceuticals industry
Countries Covered : World
Date : 1999 Price : £ 475

Report Number : 2721-031T
Oligonucleotide Players
Pharmaceuticals - oligonucleotides
Countries Covered : World
Date : 1999 Price : £ 375

Report Number : 2721-031V
Personalised Medicine
Pharmaceuticals - research development
Countries Covered : World
Date : 2001 Price : £ 795

Report Number : 2721-031X
Pulmonary Diseases
Pharmaceuticals for pulmonary diseases
Countries Covered : World
Date : 1999 Price : £ 625

Report Number : 2721-033
Market Dynamics 1999 Cardiac Disease: Seven-Country Analysis & Perspective
Countries Covered : World
Date : 1999 Price : £ 2,995

Report Number : 2721-034
New Product Reviews
Dopexamine, lomefloxacin, ketorolac, granisetron, bupropion, citalopram, flupirtine, interleukin-2, nafarelin, ondansetron, paroxetine, enoximone, amlodipine, vigabatrin, octreotide: impact on market; pharmacology; pharmacokinetics; toxicology; trials
Countries Covered : World
Scope : 50pp Price : £ 100-135/P Frequency : On Demand

Report Number : 2721-035
World Market for Anti-infectives, Vol.2: Antibacterial Medications
Clinical, regulatory, business & political forces shaping the market
Countries Covered : World
Scope : 168pp Date : 2003 Price : $2,500

Report Number : 2721-035A
Congestive Heart Failure: Worldwide Drug and Medical Device Markets
Reviews the current state of the markets in this expanding field, including developments in drug therapy and technological advances in the device markets
Countries Covered : World
Scope : 334pp Date : 2002 Price : $2,625

Report Number : 2721-035B
World Market for Anti-infectives, Vol. 3: Antiviral Medications
Analysis of the world market for non-vaccine antiviral medication
Countries Covered : World
Scope : 120+pp Date : 2003 Price : $2,375

Report Number : 2721-035C
Parkinson's Disease; from The World Market for Neurotherapeutic Drugs
Countries Covered : World
Scope : 214pp Date : 2002 Price : $1,495

Report Number : 2721-035D
Multiple Sclerosis; from The World Market for Neurotherapeutic Drugs
Countries Covered : World
Scope : 158pp Date : 2002 Price : $1,495

Report Number : 2721-035E
Neurological Cancers; from The World Market for Neurotherapeutic Drugs
Countries Covered : World
Scope : 250pp Date : 2003 Price : $1,495

Report Number : 2721-035F
The World Market for Neurotherapeutic Drugs
Reviews current therapeutic approaches as well as forward-looking technologies, such as biological therapy, immunotherapy, and gene therapy; provides competitive and strategic analysis and overview of regulatory and clinical trends
Countries Covered : World
Scope : 485pp Date : 2002 Price : $3,500

Report Number : 2721-035G
The World Market for Anti-infectives Series, Vols 1-3
Antifungals, antibacterials and antivirals. Forecasts the world market for anti-fungal therapies through 2006 and offers details on specific segments of the market. Also examines patent and exclusivity expiration timing and issues for key anti-fungal pharmaceuticals
Countries Covered : World
Scope : 350+pp Date : 2003 Price : $5,700

Report Number : 2721-035H
The Worldwide Market for Prescription Dermatological Drugs
Analysis of domestic and international markets involving pharmaceuticals to treat skin diseases and disorders. Market information for 1996 to 2006 (focus year 2001). Overview and product descriptions of general adjunctive therapy segments. Issues and trends affecting the market, research and developments, demographics, etc. Profiles of major market participants
Countries Covered : World
Scope : 318pp Date : 2002 Price : $3,500

Report Number : 2721-035I
The Worldwide Market for Pediatric Drugs
Status & future prospects (through 2006) of pediatric drug markets worldwide, including market size, growth and share information. Demographic data, epidemiological statistics, corporate profiles
Countries Covered : World
Scope : 538pp Date : 2002 Price : $3,500

Report Number : 2721-035J
The World Market for Anti-infectives: Vol. 1, Anti-fungal Medications
Overview of the world market for antifungal medications, including major and niche companies. Forecasts through 2006; details on specific segments of the market. Examines patent and exclusivity expiration timing and issues for many key anti-fungal pharmaceuticals
Countries Covered : World
Scope : 130pp Date : 2002 Price : $2,500

Report Number : 2721-035K
Alzheimer's Disease
Selection from 'The World Market for Neurotherapeutic Drugs'
Countries Covered : USA
Scope : 232pp Date : 2002 Price : $1,495

Report Number : 2721-035L
The Global Market for Prescription Antifungal Drugs
Concise summary of relevant market information
Countries Covered : World
Scope : 13pp;E Date : 2000 Price : $399

Report Number : 2721-035M
The Global Market for Prescription Dermatitis, Seborrhea & Psoriasis Drugs
Concise summary of relevant market information
Countries Covered : USA
Scope : 14pp;E Date : 2002 Price : $399

Report Number : 2721-035N
The Global Market for Prescription Antiacne Drugs
Concise summary of relevant market information
Countries Covered : USA
Scope : 14pp;E Date : 2002 Price : $399

Report Number : 2721-035P
The Global Market for Prescription Hair Loss and Hair Removal Drugs
Concise summary of relevant market information
Countries Covered : World
Scope : 14pp;E Date : 2002 Price : $399

Report Number : 2721-035Q
The Global Market for Miscellaneous Prescription Dermatological Drugs
Concise summary of relevant market information
Countries Covered : USA
Scope : 12pp;E Date : 2002 Price : $399

Report Number : 2721-035R
The Global Market for Prescription Anti-aging and Photodamage Drugs
Concise summary of relevant market information
Countries Covered : USA
Scope : 12pp;E Date : 2002 Price : $399

Report Number : 2721-037
Markets for Cell-signalling Pathway Therapeutics
Diabetes, cancer, auto-immune diseases and inflammatory diseases. Secondary research
Countries Covered : Japan, W. Europe, UK, USA
Date : 2000 Price : $3,200

Report Number : 2721-038
Drug delivery in Central Nervous System Diseases
Technologies and commercial opportunities. Secondary research
Countries Covered : W. Europe, UK, USA
Date : 2000 Price : $3,200

Report Number : 2721-039
Outlook for Neuroprotectants
Next-generation therapies for stroke, traumatic brain injury, and spinal cord injury. Secondary research
Countries Covered : Japan, W. Europe, UK, USA
Date : 2000 Price : $3,200

Report Number : 2721-040
Outlook for Antisense Therapeutics
Cancer, inflammatory disorders, infectious disease, and bestenosis. Secondary research
Countries Covered : Japan, W. Europe, UK, USA
Date : 1999 Price : $3,200

Report Number : 2721-041
Top Cancer Biopharmaceuticals
Evaluation and outlook. Secondary research
Countries Covered : Japan, W. Europe, UK, USA
Date : 1999 Price : $3,200

Report Number : 2721-042
Outlook for Ctyokine and Anticytokine Therapeutics
Hematology, inflammatory and autoimmune disorders, infectious disease, and cancer. Secondary research
Countries Covered : Japan, W. Europe, UK, USA
Date : 1999 Price : $3,200

Report Number : 2721-043
Next-generation Central Nervous System Therapeutics
Analysis of 15 therapeutic pipelines. Secondary research
Countries Covered : Japan, W. Europe, UK, USA
Date : 1999 Price : $5,000

Report Number : 2721-044
Obesity
Analysis of epidemiology, medical practice, and commercial outlook for current and emerging therapies. Primary and secondary research in seven major markets
Countries Covered : Japan, W. Europe, UK, USA
Scope : 126pp Date : 2000 Price : $14,000

Report Number : 2721-045
Emerging Matrix Metalloproteinase Inhibitors
Analysis of epidemiology, medical practice, and commercial outlook for current and emerging therapies. Primary and secondary research in seven major markets
Countries Covered : Japan, W. Europe, UK, USA
Scope : 112pp Date : 2000 Price : $14,000

Report Number : 2721-046
Hormone Replacement Therapy
Analysis of epidemiology, medical practice and commercial outlook for current and emerging therapies. Primary and secondary research in seven major markets
Countries Covered : Japan, W. Europe, UK, USA
Scope : 123pp Date : 1999 Price : $14,000

Report Number : 2721-047
Glycoprotein IIb/IIIa Receptor Antagonists
Analysis of epidemiology, medical practice and commercial outlook for current and emerging therapies. Primary and secondary research in seven major markets
Countries Covered : Japan, W. Europe, UK, USA
Scope : 95pp Date : 2000 Price : $18,500

Report Number : 2721-048
Marketing: Environment for Cardiovascular Agents
Analysis of epidemiology, medical practice and commercial outlook for current and emerging therapies. Primary and secondary research in seven major markets
Countries Covered : Japan, W. Europe, UK, USA
Scope : 59pp Date : 2000 Price : $18,500

Report Number : 2721-049
Strategic Overview of Antiviral Markets
Analysis of epidemiology, medical practice and commercial outlook for current and emerging therapies. Primary and secondary research in seven major market
Countries Covered : Japan, W. Europe, UK, USA
Scope : 78pp Date : 2000 Price : $18,500

Report Number : 2721-050
Antibacterial Drug Resistance
Analysis of epidemiology, medical practice and commercial outlook for current and emerging therapies. Primary and secondary research in seven major markets
Countries Covered : Japan, W. Europe, UK, USA
Scope : 81pp Date : 2000 Price : $18,500

Report Number : 2721-051
Emerging Antibacterial Agents
Analysis of epidemiology, medical practice and commercial outlook for current and emerging therapies. Primary and secondary research in seven major markets
Countries Covered : Japan, W. Europe, UK, USA
Scope : 95pp Date : 1999 Price : $18,500

Report Number : 2721-052
Issues in Chemotherapy Reimbursement
Analysis of epidemiology, medical practice and commercial outlook for current and emerging therapies. Primary and secondary research in seven major markets
Countries Covered : Japan, W. Europe, UK, USA
Scope : 48pp Date : 2000 Price : $18,500

Report Number : 2721-053
Managing the Side-effects of Chemotherapy
Analysis of epidemiology, medical practice and commercial outlook for current and emerging therapies. Primary and secondary research in seven major markets
Countries Covered : Japan, W. Europe, UK, USA
Scope : 160pp Date : 1999 Price : $18,500

Report Number : 2721-055
The European Market for Erectile Dysfunction Therapies & Devices (E3612)
Market size, growth and forecasts; therapy developments; major market players and new entrants
Countries Covered : W. Europe
Date : 1999 Price : £ 3,950

Report Number : 2721-067
The Treatment of Multiple Sclerosis in Europe
Market analysis: drugs used; treatment history; patient profile; physician usage
Countries Covered : Germany, Spain, France, Italy, Netherlands, Sweden, UK
Price : On Request Frequency : 2 per Year

Report Number : 2721-069
Protein Drugs: Manufacturing Technologies
Examination of protein drug manufacture, including lab vs commercial production, choice of method, scale-up, upstream manipulation; issues addressed include glycosylation, contamination and regulations; also covered are source extraction, fermentation, cell culture, chemical synthesis, transgenic animals, down-stream processing (including purification and formulation) and input materials for protein drug production
Countries Covered : USA
Scope : 273pp Date : 2000 Price : $3,450

Report Number : 2721-073
Biochips
Historical demand data (1998, 2001, 2003) plus forecasts to 2008 and 2013 by product, service, application and market. Also reviews technology, evaluates market shares and profiles nearly 40 US industry competitors
Countries Covered : USA
Date : 2004 Price : $4,100

Report Number : 2721-079
Medical Trends in Antibiotics
Antibiotic usage in 450 hospitals based on case records - 2 vols.: teaching and non-teaching hospitals: indication, surgical procedure, combination usage, dosage, prior antibiotics & reason for change, duration, primary pathogen
Countries Covered : USA
Price : $27,000/S Frequency : Every 6 Months

Report Number : 2721-080
Analgesics
US consumer intelligence report
Countries Covered : USA
Date : 2002 Price : $2,995

Report Number : 2721-081
Biologics
This study provides historical data, and forecasts to 2006 and 2011 for biologic products by type, application and end-use market. Opportunities for fine chemical companies also analyzed. In addition, the study assesses the competitive structure of the US biologics industry, and includes profiles of major companies participating in the field
Countries Covered : USA
Date : 2002 Price : $3,800

Report Number : 2721-082
Enabling Technologies in Drug Discovery Research Package
Examines competing technologies, and the alliances being formed in the proteomics arena today
Countries Covered : USA
Scope : 564pp Date : 2002 Price : $2,999

Report Number : 2721-083
The US Market for Pain Management Drugs and Devices
Overview of pain medical devices and pharmaceutical preparations to treat pain, and issues and trends affecting pain management. Markets divided according to product category. Market data and forecasts for 2001-06 expressed in US dollars at the wholesale level. Also discusses clinical and business trends affecting the market, pain management services and alternative therapies, and profiles the top competitors in the field
Countries Covered : USA
Scope : 250pp Date : 2003 Price : $3,500

Report Number : 2721-084
The US Market for Prescription Dermatological Drugs
Describes US revenues and growth rate trends for anti-acne, anti-aging, anti-fungal, hair loss, topical corticosteroids and other nonsteroidal prescription dermatological drugs for 1994-2004
Countries Covered : USA
Scope : 237pp Date : 2000 Price : $1,625

Report Number : 2721-085
The Market for Psychotherapeutic Drugs
overview of mental health diseases and the common medical treatments used. Analysis of various product market categories and competitors; insights and explorations of critical issues involving mental health. Competitor profiles
Countries Covered : USA
Scope : 352pp Date : 1999 Price : $3,250

Report Number : 2721-086
The Anti-infectives Market
Coverage of the US market for existing and emerging anti-infective drugs. Market analysis, including historical, current and forecast market size, for each of the market segments. Information on products in development and their impact on the market; profiles of major competitors
Countries Covered : USA
Scope : 246pp Date : 1999 Price : $3,250

Report Number : 2721-087
The Market for Prescription Generic Drugs
Major therapeutic categories for generic drugs 1995-2004. Issues affecting the market; existing and possible strategies; profiles of leading drug company participants
Countries Covered : USA
Scope : 268pp Date : 2000 Price : $2,112

Report Number : 2721-088
The Market for Pain Management Products and Services
Market trends; overview of drugs and devices currently available and in development; innovative drug delivery technologies and trends discussed; historical data and projections through 2003; profiles of major competitors
Countries Covered : USA
Scope : 236pp Date : 1999 Price : $3,250

Report Number : 2721-089
The Market for Vaccines
Recent product approvals and developments in the vaccines market. Forecast sales to 2004; assessment of pharmaceutical company leaders
Countries Covered : USA
Scope : 229pp Date : 2000 Price : $2,112

Report Number : 2721-091
The Antinauseants and Antiemetics Market in Cancer Therapy
Concise summary of relevant market information
Countries Covered : USA
Scope : 16pp;E Date : 2002 Price : $399

Report Number : 2721-092
Pediatric Allergy and Respiratory Drugs
Concise summary of relevant market information
Countries Covered : USA
Scope : 16pp;E Date : 2002 Price : $399

Report Number : 2721-093
Pediatric Gastrointestinal Drugs
Concise summary of relevant market information
Countries Covered : USA
Scope : 16pp;E Date : 2002 Price : $399

Report Number : 2721-094
Pediatric Central Nervous System Drugs
Concise summary of relevant market information
Countries Covered : USA
Scope : 16pp;E Date : 2002 Price : $399

Report Number : 2721-095
Prescription Generic Cardiovascular Drugs
Concise summary of relevant market information
Countries Covered : USA
Scope : 16pp;E Date : 2002 Price : $399

Report Number : 2721-096
Prescription Generic Allergy and Respiratory Drugs
Concise summary of relevant market information
Countries Covered : USA
Scope : 17pp;E Date : 2002 Price : $399

Report Number : 2721-097
Prescription Generic Central Nervous System and Psychotherapeutic Drugs
Concise summary of relevant market information
Countries Covered : USA
Scope : 22pp;E Date : 2002 Price : $399

Report Number : 2721-101
The Market for Diabetes Drugs
Concise summary of relevant market information
Countries Covered : USA
Scope : 16pp;E Date : 2000 Price : $399

Report Number : 2721-102
The US Market for Prescription Generic Drugs
Concise summary of relevant market information
Countries Covered : USA
Scope : 18pp;E Date : 2000 Price : $399

Report Number : 2721-103
The US Market for Penicillin
Concise summary of relevant market information
Countries Covered : USA
Scope : 13pp;E Date : 1999 Price : $499

Report Number : 2721-104
The US Market for Quinolones
Concise summary of relevant market information
Countries Covered : USA
Scope : 15pp;E Date : 1999 Price : $299

Report Number : 2721-105
The US Market for Beta-Lactamase Inhibitors
Concise summary of relevant market information
Countries Covered : USA
Scope : 16pp;E Date : 1999 Price : $299

Report Number : 2721-106
The US Market for Systemic Antifungals
Concise summary of relevant market information
Countries Covered : USA
Scope : 18pp;E Date : 1999 Price : $299

Report Number : 2721-107
The US Market for Tetracyclines
Concise summary of relevant market information
Countries Covered : USA
Scope : 13pp;E Date : 1999 Price : $299

Report Number : 2721-108
The US Market for Cephalosporins
Concise summary of relevant market information
Countries Covered : USA
Scope : 15pp;E Date : 1999 Price : $299

Report Number : 2721-109
The US Market for Macrolides
Concise summary of relevant market information
Countries Covered : USA
Scope : 16pp;E Date : 1999 Price : $299

Report Number : 2721-111
The Market for Pediatric Preventive Vaccines
Concise summary of relevant market information
Countries Covered : USA
Scope : 17pp;E Date : 2000 Price : $399

Report Number : 2721-112
The Market for Adult Preventive Vaccines
Concise summary of relevant market information
Countries Covered : USA
Scope : 18pp;E Date : 2000 Price : $399

Report Number : 2721-113
The US Market for Psychotherapeutic Drugs: Stimulants
Concise summary of relevant market information
Countries Covered : USA
Scope : 15pp;E Date : 1999 Price : $299

Report Number : 2721-114
The US Market for Psychotherapeutic Drugs: Antipsychotics
Concise summary of relevant market information
Countries Covered : USA
Scope : 13pp;E Date : 1999 Price : $299

Report Number : 2721-115
The US Market for Psychotherapeutic Drugs: Depressives
Concise summary of relevant market information
Countries Covered : USA
Scope : 14pp;E Date : 1999 Price : $299

Report Number : 2721-116
The US Market for Women's Health Drugs
Concise summary of relevant market information
Countries Covered : USA
Scope : 14pp;E Date : 2000 Price : $399

Report Number : 2721-117
Epilepsy
Selections from 'The World Market for Neurotherapeutic Drugs'
Countries Covered : World
Scope : 202pp Date : 2002 Price : $1,495